Authors
Loading...
Experimental study reveals TRIM40 drives intestinal barrier breakdown in inflammatory bowel disease, highlighting a therapeutic target for chronic gut inflammation.
Kang et al. (2023) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: